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The Gut in Metabolic Disease
The gastrointestinal tract (GIT) is responsible for the digestion of food and absorption of water and nutrients. Resection of different parts of the GIT is known to cause nutrient deficiencies, for example, terminal ileal resection causes vitamin B12 and bile salt malabsorption. Recent research has revealed that in addition to its role in nutrient digestion and absorption, the GIT may also play a role in diseases, for example, cancer, obesity and metabolic disease.
In this issue of Proceedings of Singapore Healthcare, we review the techniques used in bariatric surgery where the storage or the absorptive capacity of the gut is compromised 1 . Some techniques merely reduce the functional volume of the stomach and hence its ability to store food during a meal. Hence laparoscopic gastric banding which constricts the stomach and sleeve gastrectomy which removes a portion of the stomach. In addition to reducing the volume of the stomach, gastric bypass surgery creates a fistula between the stomach and the jejunum, hence reducing the time food will spend in the stomach and food passes quickly into the jejunum. Bypass surgeries, for example, the Rouxen-Y gastric bypass, reduces the effective length of intestines available for nutrient absorption. These techniques reduce the amount of nutrients absorbed and help patients reduce weight. However, in addition to weight reduction, patients with diabetes mellitus achieved better blood sugar control more quickly than one would expect if the effects were all due to weight loss 2 . We are now just beginning to learn the effects of bariatric surgery on the various gut hormones, for example, Peptide YY and glucagon like peptide-1 (GLP1) and the downstream effects on metabolism 3 .
Stool is thought of as a waste product teeming with bacteria. Only a minority of these bacteria can be cultured in the laboratory. The majority of bacteria in the stool cannot be cultured and it is only with the development of sequencing technology in the last 10 years that scientists have been able to get a glimpse of the complexity of the stool microbiota. Scientists and doctors have made use of this newfound ability to determine if certain combinations of stool microbiota or if individual species of bacteria associate with certain diseases. It was not unexpected that associations were found with gastrointestinal diseases, for example, inflammatory bowel diseases. What was more surprising was the association of some combinations of stool microbiota with obesity and metabolic syndrome 4,5 . While we have traditionally thought that people become obese because of the imbalance between the number of calories consumed and the number expanded, new research suggests that the composition of bacteria in the stools may have something to do with obesity. Some bacteria are able to digest polysaccharides not normally digested by human digestive enzymes, others are able to synthesise fatty acid synthetase, hence making more nutrients available for absorption. The next logical question to ask then is what determines the composition of our stool microbiota. Is it determined by the food that we eat, the antibiotics we consume, or is it determined by the gut immune system? These are exciting times in which we live. We have acquired new knowledge of the role of the gut in obesity and metabolic diseases. I look forward to the day when this new knowledge is translated into therapy for obese and diabetic patients.
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